The objectives of this paper is to investigate, demonstrate, and compare the mechanism of action of phytocannabinoids as antidiabetic and anti-obesity agents in preadipocytes and adipocytes, relative to rosiglitazone and metformin. Briefly, cannabis extract, Δ9-tetrahydrocannabinol and cannabidiol (in very low dosages) were shown to promote glucose uptake higher or to equivalent levels, reduce fat accumulation, and reverse the insulin-resistant state of 3T3-L1 cells more effectively, relative to rosiglitazone and metformin. The phytocannabinoids had a more pronounced effect in preadipocytes undifferentiated model rather than the differentiated model. They induced a protective effect at the mitochondrial level by preventing overactivity of the succinate dehydrogenase pathway (p
CITATION STYLE
Ramlugon, S., Levendal, R. A., & Frost, C. L. (2018). Time-dependent effect of phytocannabinoid treatments in fat cells. Phytotherapy Research, 32(6), 1080–1089. https://doi.org/10.1002/ptr.6047
Mendeley helps you to discover research relevant for your work.